Actinic Keratoses affect millions of people worldwide and can significantly impact quality of life.
As clinicians continue to explore non-invasive treatment options, the SteriPlas Premium Cold Plasma is generating increasing interest. The SteriPlas provides a contact-free treatment that can be incorporated into medical dermatology practice whilst maintaining excellent patient comfort.
This growing interest is underpinned by a substantial body of published clinical research. Numerous peer-reviewed studies have demonstrated the potential of the SteriPlas across medical dermatology, including the treatment of actinic keratoses, with encouraging clinical outcomes and an excellent safety profile.
As the evidence continues to expand, the SteriPlas is becoming an increasingly important technology within modern dermatological practice.
We’re excited to be helping drive the future of evidence-based plasma medicine.
